string(142) "/en/component/flexicontent/item/513-crs-2005-relevance-of-usp-methodology-in-the-development-of-a-verapamil-hydrochloride-240mg-er-formulation"
English
string(143) "/es/component/flexicontent/item/2438-crs-2005-relevance-of-usp-methodology-in-the-development-of-a-verapamil-hydrochloride-240mg-er-formulation"
Español
string(142) "/en/component/flexicontent/item/513-crs-2005-relevance-of-usp-methodology-in-the-development-of-a-verapamil-hydrochloride-240mg-er-formulation"
English
string(143) "/es/component/flexicontent/item/2438-crs-2005-relevance-of-usp-methodology-in-the-development-of-a-verapamil-hydrochloride-240mg-er-formulation"
Español
string(142) "/en/component/flexicontent/item/513-crs-2005-relevance-of-usp-methodology-in-the-development-of-a-verapamil-hydrochloride-240mg-er-formulation"
English
string(143) "/es/component/flexicontent/item/2438-crs-2005-relevance-of-usp-methodology-in-the-development-of-a-verapamil-hydrochloride-240mg-er-formulation"
Español